Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Position Reduced by Gilman Hill Asset Management LLC

Gilman Hill Asset Management LLC trimmed its position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 4.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 603,557 shares of the real estate investment trust’s stock after selling 25,156 shares during the quarter. Sabra Health Care REIT makes up about 1.8% of Gilman Hill Asset Management LLC’s portfolio, making the stock its 7th biggest holding. Gilman Hill Asset Management LLC owned 0.26% of Sabra Health Care REIT worth $10,454,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. ORG Partners LLC increased its stake in shares of Sabra Health Care REIT by 2,031.8% in the 4th quarter. ORG Partners LLC now owns 25,283 shares of the real estate investment trust’s stock valued at $438,000 after purchasing an additional 24,097 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Sabra Health Care REIT by 222.4% in the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock valued at $183,996,000 after buying an additional 6,819,919 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Sabra Health Care REIT by 12.3% during the 3rd quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock worth $9,543,000 after buying an additional 57,551 shares during the period. Wilmington Savings Fund Society FSB purchased a new position in shares of Sabra Health Care REIT during the 3rd quarter valued at approximately $59,000. Finally, Geode Capital Management LLC lifted its position in shares of Sabra Health Care REIT by 1.7% during the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock valued at $117,165,000 after buying an additional 104,533 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Health Care REIT Price Performance

NASDAQ:SBRA opened at $16.94 on Monday. The stock has a 50 day moving average price of $17.71 and a 200 day moving average price of $17.54. The stock has a market cap of $4.01 billion, a PE ratio of 41.32, a P/E/G ratio of 2.05 and a beta of 1.26. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. Sabra Health Care REIT, Inc. has a one year low of $12.83 and a one year high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The company had revenue of $178.00 million for the quarter, compared to analysts’ expectations of $177.19 million. During the same quarter in the prior year, the firm earned $0.34 EPS. Equities research analysts expect that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 7.08%. Sabra Health Care REIT’s dividend payout ratio (DPR) is 292.69%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on SBRA. Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a research report on Tuesday, January 7th. Mizuho reaffirmed a “neutral” rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Scotiabank boosted their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research note on Friday, October 11th. Finally, Wells Fargo & Company upgraded Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $16.00 to $20.00 in a research report on Tuesday, October 1st. Three research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Sabra Health Care REIT currently has a consensus rating of “Moderate Buy” and an average target price of $19.13.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.